血液透析通路功能障碍首次PTA成功后的通畅性影响因素
该回顾性观察研究纳入126例患者共132次首次PTA成功且随访≥1年的血液透析通路,发现初次和二次通畅时间分别为16个月和27个月。血脂异常、胰岛素使用和AVG与初次通畅缩短相关,他汀使用与初次及二次通畅延长相关,AVF和功能衰竭型通路通畅率更高。
要点
- 血液透析通路首次PTA成功后初次通畅平均16个月,二次通畅平均27个月。
- 血脂异常、胰岛素使用和AVG是初次通畅缩短的独立预测因素。
- 他汀使用与初次及二次通畅延长相关,AVF和功能衰竭型通路通畅率更高。
核心结论
- AVF和功能衰竭型通路首次PTA成功后初次及二次通畅率显著高于AVG和功能丧失型通路。
- 他汀使用与首次PTA成功后初次及二次通畅延长相关。
研究设计与样本
- 回顾性观察研究纳入126例患者共132次首次PTA,均即刻技术及临床成功且随访至少1年。
主要发现
- PTA后初次通畅平均16个月,二次通畅平均27个月。
- 多因素校正Cox回归显示血脂异常(P<0.001)、胰岛素使用(P=0.016)和AVG(P=0.016)与初次通畅缩短显著相关。
- 血脂异常(P<0.001)、抗血小板药物使用(P=0.013)和通路失效(P=0.004)是二次通畅丧失的显著预测因素。
- 他汀使用是唯一与初次及二次通畅增加相关的临床变量(P<0.001)。
- AVG和功能丧失型通路首次PTA后6个月内早期功能障碍显著更高,但多次PTA后无显著差异。
临床怎么用
- 对血液透析通路首次PTA成功后患者,应关注血脂异常、胰岛素使用和AVG等通畅不良预测因素。
- 他汀使用可能与改善PTA后通畅性相关,AVF和功能衰竭型通路预后更优。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to investigate the patency following initial successful percutaneous transluminal angioplasty (PTA) for untreated dysfunctional hemodialysis vascular access and to identify predictors of PTA durability. METHODS: This retrospective observational study included data of 132 consecutive initial PTA of hemodialysis vascular access in 126 patients who showed immediate technical and clinical success and had at least 1 year of follow-up data. RESULTS: The mean duration of primary and secondary patency post-PTA was 16 and 27 months, respectively. On multivariate adjusted Cox regression analysis, dyslipidemia (P < 0.001), use of insulin (P = 0.016), and arteriovenous graft (AVG) (P = 0.016) were significantly associated with shorter primary patency. Dyslipidemia (P < 0.001), use of antiplatelet medication (P = 0.013), and failed vascular access (P = 0.004) were significant predictors of secondary patency loss. Use of statin was the only clinical variable associated with increased primary and secondary patency (P < 0.001). According to a subgroup analysis on the type of vascular access and dysfunction, primary and secondary patency rates were significantly higher in the arteriovenous fistula (AVF) and failing vascular access groups than AVG and failed vascular access groups, respectively. Early dysfunction (within 6 months) was significantly higher in the AVG and failed vascular access groups after initial PTA, but there was no significant difference after multiple PTAs. CONCLUSIONS: Post-PTA primary and secondary patency rates were significantly higher with AVF and failing vascular access. The use of statin was associated with increased primary and secondary patency after initial successful PTA in this study.
引用
- Kim SM, Ko HK, Noh M, et al. Factors Affecting Patency following Successful Percutaneous Intervention for Dysfunctional Hemodialysis Vascular Access. Ann Vasc Surg. 2017. PMID: 28887254. doi:10.1016/j.avsg.2017.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。